Compare OCGN & FWDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OCGN | FWDI |
|---|---|---|
| Founded | 2013 | 1961 |
| Country | United States | United States |
| Employees | N/A | 60 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Plastic Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 387.3M | 376.6M |
| IPO Year | 2014 | N/A |
| Metric | OCGN | FWDI |
|---|---|---|
| Price | $1.62 | $4.85 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 5.0M | 819.2K |
| Earning Date | 06-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.58 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $407.02 |
| Revenue Next Year | $4,139.02 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.52 | $4.06 |
| 52 Week High | $2.00 | $9.28 |
| Indicator | OCGN | FWDI |
|---|---|---|
| Relative Strength Index (RSI) | 48.33 | 44.67 |
| Support Level | $1.44 | $4.53 |
| Resistance Level | $1.88 | $8.82 |
| Average True Range (ATR) | 0.16 | 0.33 |
| MACD | 0.01 | 0.15 |
| Stochastic Oscillator | 37.90 | 62.65 |
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
Forward Industries Inc is a provider of carrying and protective solutions. The company operates in two segments: design and digital assets. The design segment consists of two operating segments (IPS and Kablooe, which have been aggregated into one reportable segment) that provide a full spectrum of hardware and software product design and engineering services to customers predominantly.